Truemeds Eyes Acquiring E-Commerce Unicorn DealShare for Over $90 Million

31 Aug 2026, 1:08 pm · 12d ago · 1 min read · Inc42

Amount

$90M

Stage

Acquisition

Online pharmacy Truemeds is reportedly in advanced discussions to acquire social e-commerce platform DealShare via a share-swap transaction valuing DealShare at just over $90 million. The proposed valuation represents a steep 95% discount from DealShare’s peak valuation of $1.7 billion achieved in 2022. Under the proposed structure, Truemeds will issue shares to DealShare’s investors at a valuation of approximately $600 million. DealShare’s valuation mirrors its existing cash balance of over $90 million, granting Truemeds access to capital without upfront cash spending. WestBridge Capital is a common investor in both Indian startups.